The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications

Heart Rhythm

Volumn 12, Issue 6, 2015, Pages 1169-1176

  Van Der Heijden, Aafke C ^a   Borleffs, C Jan Willem ^a   Buiten, Maurits S ^a   Thijssen, Joep ^a   Van Rees, Johannes B ^a   Cannegieter, Suzanne C ^a   Schalij, Martin J ^a   Van Erven, Lieselot ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac resynchronization therapy; Defibrillator therapy; Device replacements; Device relatedcomplications; Implantable cardioverter defibrillator

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DEVICE FAILURE; DEVICE INFECTION; DEVICE THERAPY; DISEASE COURSE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS INTERVAL; SECONDARY PREVENTION; SHOCK; ADVERSE EFFECTS; AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DEVICE REMOVAL; MIDDLE AGED; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84929220862     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.02.035     Document Type: Article

References (28)

1. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
2. A. Kadish, A. Dyer, and J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
3. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Multicenter Automatic Defibrillator Implantation Trial III. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
5. S.J. Connolly, M. Gent, R.S. Roberts, P. Dorian, D. Roy, R.S. Sheldon, L.B. Mitchell, M.S. Green, G.J. Klein, and B. O'Brien Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
6. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, H. Klein, J.H. Levine, S. Saksena, A.L. Waldo, D. Wilber, M.W. Brown, and M. Heo Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940
7. F. Bokhari, D. Newman, M. Greene, V. Korley, I. Mangat, and P. Dorian Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS) Circulation 110 2004 112 116
8. I. Goldenberg, J. Gillespie, A.J. Moss, W.J. Hall, H. Klein, S. McNitt, M.W. Brown, I. Cygankiewicz, and W. Zareba Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II Circulation 122 2010 1265 1271
9. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
10. F. Ronn, M. Kesek, N. Hoglund, and S.M. Jensen Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular function Scand Cardiovasc J 42 2008 125 129
11. H. Tandri, L.S. Griffith, T. Tang, K. Nasir, O. Zardkoohi, C.V. Reddy, M. Capps, H. Calkins, and J.K. Donahue Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators Heart Rhythm 3 2006 762 768
12. G.H. van Welsenes, J.B. van Rees, C.J. Borleffs, S.C. Cannegieter, J.J. Bax, L. van Erven, and M.J. Schalij Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients Europace 13 2011 389 394
13. D. Wilson, B. Shi, S. Harding, N. Lever, and P. Larsen Implantable cardioverter-defibrillators: a long-term view Intern Med J 42 2012 554 561
14. P.J. Bradshaw, P. Stobie, T. Briffa, and M.S. Hobbs Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009 Am Heart J 165 2013 816 822
15. L.A. Saxon, D.L. Hayes, F.R. Gilliam, P.A. Heidenreich, J. Day, M. Seth, T.E. Meyer, P.W. Jones, and J.P. Boehmer Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study Circulation 122 2010 2359 2367
16. H. Putter, M. Fiocco, and R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389 2430
17. T.R. Betts, P.P. Sadarmin, D.R. Tomlinson, K. Rajappan, K.C. Wong, J.P. de Bono, and Y. Bashir Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis Europace 15 2013 813 819
18. M.R. Gold, J.C. Daubert, W.T. Abraham, C. Hassager, J.L. Dinerman, J.H. Hudnall, J. Cerkvenik, and C. Linde Implantable defibrillators improve survival in mildly symptomatic heart failure patients receiving cardiac resynchronization therapy: analysis of the long-term follow-up of REVERSE Circ Arrhythm Electrophysiol 6 2013 1163 1168
19. I. Goldenberg, V. Kutyifa, and H.U. Klein Survival with cardiac-resynchronization therapy in mild heart failure N Engl J Med 370 2014 1694 1701
20. A.A. Alsheikh-Ali, M. Homer, P.V. Maddukuri, B. Kalsmith, N.A. Estes III, and M.S. Link Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 784 789
21. A.C. van der Heijden, J. Thijssen, C.J. Borleffs, J.B. van Rees, U. Hoke, E.T. van der Velde, L. van Erven, and M.J. Schalij Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients Heart 99 2013 1244 1249
22. J.P. Daubert, W. Zareba, and D.S. Cannom Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
23. M.S. Wathen, P.J. DeGroot, M.O. Sweeney, A.J. Stark, M.F. Otterness, W.O. Adkisson, R.C. Canby, K. Khalighi, C. Machado, D.S. Rubenstein, K.J. Volosin, and FRIII Pain Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596
24. B.L. Wilkoff, B.D. Williamson, and R.S. Stern Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
25. A.J. Moss, C. Schuger, and C.A. Beck Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
26. A.J. Greenspon, J.D. Patel, E. Lau, J.A. Ochoa, D.R. Frisch, R.T. Ho, B.B. Pavri, and S.M. Kurtz 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008 J Am Coll Cardiol 58 2011 1001 1006
27. C.J. Borleffs, L. van Erven, R.J. van Bommel, E.T. van der Velde, E.E. van der Wall, J.J. Bax, F.R. Rosendaal, and M.J. Schalij Risk of failure of transvenous implantable cardioverter-defibrillator leads Circ Arrhythm Electrophysiol 2 2009 411 416
28. T. Kleemann, T. Becker, K. Doenges, M. Vater, J. Senges, S. Schneider, W. Saggau, U. Weisse, and K. Seidl Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years Circulation 115 2007 2474 2480